SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (2631)9/25/1997 12:12:00 AM
From: biowa   of 9719
 
Henry,

>>Both LGND and AGN will develop everything for everything and everything will be cross licensed.<<

As I read the PR, don't you mean "develop half of everything for everything, and license the other to the other (party)?" Just wanted to climb the mountain and consult the bhottisatva of Ligand to make sure I had it right.

Actually, this should be a longer-term positive for LGND since it cleans up any potential ownership issues, though we'll see how it plays out in the short-term (dilution, loss of arbitrage plays between LGND and ALRT, etc.)

On another note, might this be partially a sign of LGND cleaning up its pre-clinical diabetes house to facilitate THE diabetes deal?

biowa
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext